Innovation – Page 16
-
NewsGroundbreaking clinical trial evaluates oncolytic virus for non-small cell lung cancer
Moffitt Cancer Center has launched a pioneering clinical trial for patients with late-stage non-small cell lung cancer, using a novel oncolytic virus, MEM-288, in combination with the immune checkpoint inhibitor nivolumab.
-
NewsPioneering oral fungal infection treatment shows promise in preclinical trials
A novel oral amphotericin B (MAT2203) developed for treatment of invasive mucormycosis (IM) and other deadly invasive fungal infections, has demonstrated encouraging results in a series of preclinical studies.
-
NewsBiodegradable ‘living plastic’ houses bacterial spores that help it break down
Researchers have developed a biodegradable form of thermoplastic polyurethane (TPU), filled with bacterial spores that, when exposed to nutrients present in compost, germinate and break down the material at the end of its life cycle.
-
NewsNew tool helps identify babies at high risk for RSV
A new tool to identify infants most at risk for severe respiratory syncytial virus (RSV) illness could aid pediatricians in prioritizing children under 1 to receive a preventive medication before RSV season (October-April).
-
NewsScientists replace fishmeal in aquaculture with microbial protein from soybean processing wastewater
Scientists have successfully replaced half the fishmeal protein in the diets of farmed Asian seabass with a ‘single cell protein’ cultivated from microbes in soybean processing wastewater, paving the way for more sustainable fish farming.
-
NewsExperts developing way to harness Nobel Prize winning CRISPR technology to deal with antimicrobial resistance (AMR)
Scientists show how the latest CRISPR-Cas gene editing technology can be used to help modify and attack AMR bacteria.
-
NewsExperimental NIH malaria monoclonal antibody protective in Malian children
One injected dose of an experimental malaria monoclonal antibody was 77% effective against malaria disease in children in Mali during the country’s six-month malaria season, according to the results of a mid-stage clinical trial.
-
NewsSynthetic droplets cause a stir in the primordial soup
A synthetic droplet may give researchers clues on how the simplest forms of life on the planet could navigate their surroundings.
-
NewsStudy finds artificial intelligence can develop treatments to prevent superbugs
Researchers developed an AI model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based solely on how quickly the bacteria grow given certain perturbations.
-
NewsVaccine candidate could fight antibiotic resistance
Scientists have announced several discoveries that will help the development of a carbohydrate-based vaccine for infections caused by Staphylococcus aureus and its “superbug” relative methicillin-resistant Staphylococcus aureus, or MRSA.
-
NewsLivestock abortion surveillance could protect livelihoods and detect emerging global pathogens
A study suggests timely reporting and investigating of livestock abortions is feasible in rural areas and can provide insights into emerging infectious diseases.
-
NewsEngineers muffle invading pathogens with a ‘molecular mask’
Researchers are developing a hydrogel therapy that acts as a first line of defense against viruses and other biological threats. The peptides that make up this gel prevent viruses such as SARS-CoV-2 from attaching to and entering cells.
-
NewsPromising patient-friendly oral drug against visceral leishmaniasis enters Phase II clinical trial in Ethiopia
The new molecule has the potential to revolutionize treatment for the deeply neglected and hard-to-treat disease, as the Eastern Africa region charts the way to its elimination.
-
NewsGold may be key element for cleaner drinking water
Researchers are exploring the use of gold to develop a novel method to rid drinking water of harmful algal blooms, or HABs, which occur when colonies of algae grow out of control and produce toxic or harmful effects on living creatures.
-
NewsDNA vaccine against zika performs well in tests on mice
A Zika vaccine developed in Brazil and tested on mice has been found to be efficacious, inducing an immune response against the virus and protecting the animals appropriately.
-
NewsScientists deploy bacteria to detect sake fraud in Japan
Researchers from Japan have identified a novel method to authenticate the source of and differentiate between sake breweries, by measuring the oxygen and nitrogen stable isotopes in nitrates within sake using denitrifying bacteria first.
-
NewsReal-time detection of infectious disease viruses by searching for molecular fingerprinting
Researchers have engineered a broadband nanogap gold spectroscopic sensor using a flexible material capable of bending to create a controlled gap.
-
NewsImproved oral cholera vaccine achieves WHO PQ
EuBiologics and the International Vaccine Institute (IVI) announced that Euvichol-S, an improved oral cholera vaccine (OCV) developed jointly by EuBiologics and IVI, has achieved World Health Organization prequalification.
-
NewsCarbon beads help restore healthy gut microbiome and reduce liver disease progression
Innovative carbon beads, invented by researchers at UCL, reduce bad bacteria and inflammation in animal models, which are linked to liver cirrhosis and other serious health issues. The study, published in Gut, found that the carbon beads, licensed to UCL-spinout Yaqrit, were effective in restoring gut health and had a ...
-
NewsResearchers deploy fungus to extract useful proteins from beer-brewing leftovers
Researchers have created a method that extracts over 80 per cent of the available protein in grain leftovers from brewing beer, commonly known as brewers’ spent grain.